日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability

撤稿:HDAC8通过维持Notch1蛋白稳定性在调控乳腺癌干细胞中发挥非表观遗传功能

Chao, Min-Wu; Chu, Po-Chen; Chuang, Hsiao-Ching; Shen, Fang-Hsiu; Chou, Chih-Chien; Hsu, En-Chi; Himmel, Lauren E; Huang, Han-Li; Tu, Huang-Ju; Kulp, Samuel K; Teng, Che-Ming; Chen, Ching-Shih

Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism

罂粟碱及其衍生物通过抑制线粒体代谢来增强实体瘤的放射敏感性。

Benej, Martin; Hong, Xiangqian; Vibhute, Sandip; Scott, Sabina; Wu, Jinghai; Graves, Edward; Le, Quynh-Thu; Koong, Albert C; Giaccia, Amato J; Yu, Bing; Chen, Ching-Shih; Papandreou, Ioanna; Denko, Nicholas C

Retraction of "Development of a Novel Class of Glucose Transporter Inhibitors"

撤回论文《新型葡萄糖转运体抑制剂的开发》

Wang, Dasheng; Chu, Po-Chen; Yang, Chia-Ning; Yan, Ribai; Chuang, Yu-Chung; Kulp, Samuel K; Chen, Ching-Shih

Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42

新型组蛋白去乙酰化酶抑制剂AR-42抑制胰腺癌转基因小鼠模型中的肿瘤生长和肌肉萎缩

Henderson, Sally E; Ding, Li-Yun; Mo, Xiaokui; Bekaii-Saab, Tanios; Kulp, Samuel K; Chen, Ching-Shih; Huang, Po-Hsien

Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents

组蛋白去乙酰化酶抑制剂 AR-42 (NSC 731438) 的 R- 和 S-对映体在啮齿动物中的临床前药代动力学研究

Cheng, Hao; Xie, Zhiliang; Jones, William P; Wei, Xiaohui Tracey; Liu, Zhongfa; Wang, Dasheng; Kulp, Samuel K; Wang, Jiang; Coss, Christopher C; Chen, Ching-Shih; Marcucci, Guido; Garzon, Ramiro; Covey, Joseph M; Phelps, Mitch A; Chan, Kenneth K

Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer.

米诺环素是一种假定的神经保护剂,在三阴性乳腺癌异种移植模型中与阿霉素-环磷酰胺化疗联合使用

Himmel Lauren E, Lustberg Maryam B, DeVries A Courtney, Poi Ming, Chen Ching-Shih, Kulp Samuel K

OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells

OSU-T315:一种新型靶向治疗药物,可拮抗AKT在慢性淋巴细胞白血病细胞中的膜定位和活化。

Liu, Ta-Ming; Ling, Yonghua; Woyach, Jennifer A; Beckwith, Kyle; Yeh, Yuh-Ying; Hertlein, Erin; Zhang, Xiaoli; Lehman, Amy; Awan, Farrukh; Jones, Jeffrey A; Andritsos, Leslie A; Maddocks, Kami; MacMurray, Jessica; Salunke, Santosh B; Chen, Ching-Shih; Phelps, Mitch A; Byrd, John C; Johnson, Amy J

Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression

细胞前列腺酸性磷酸酶(cPAcP)可作为组蛋白去乙酰化酶(HDAC)抑制剂在抑制前列腺癌细胞生长方面的有用生物标志物。

Chou, Yu-Wei; Lin, Fen-Fen; Muniyan, Sakthivel; Lin, Frank C; Chen, Ching-Shih; Wang, Jue; Huang, Chao-Cheng; Lin, Ming-Fong

Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators

开发强效腺苷单磷酸活化蛋白激酶 (AMPK) 激活剂

Dokla, Eman M E; Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah A T; Ismail, Nasser S M; Abouzid, Khaled A M; Chen, Ching-Shih

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation

硝唑啉作为潜在的抗癌药物在人类前列腺癌中的应用:其在AMPK/mTOR信号通路中的关键作用以及与Chk2激活的相互作用

Chang, Wei-Ling; Hsu, Lih-Ching; Leu, Wohn-Jenn; Chen, Ching-Shih; Guh, Jih-Hwa